Literature DB >> 12639826

Is there a need for cholesteryl ester transfer protein inhibition?

Paolo Parini, Lawrence L Rudel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12639826     DOI： 10.1161/01.ATV.0000060447.25136.1C

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN： 1079-5642            Impact factor:   8.311


× No keyword cloud information.
  8 in total

1.  Single dose pharmacokinetics, pharmacodynamics, tolerability and safety of BAY 60-5521, a potent inhibitor of cholesteryl ester transfer protein.

Authors:  Michael-Friedrich Boettcher; Roland Heinig; Carsten Schmeck; Christian Kohlsdorfer; Matthias Ludwig; Anja Schaefer; Sabine Gelfert-Peukert; Georg Wensing; Olaf Weber
Journal:  Br J Clin Pharmacol       Date:  2012-02       Impact factor: 4.335

Review 2.  Novel concepts in HDL pharmacology.

Authors:  Alan T Remaley; Giuseppe D Norata; Alberico L Catapano
Journal:  Cardiovasc Res       Date:  2014-06-20       Impact factor: 10.787

Review 3.  HDL: to treat or not to treat?

Authors:  Angela Pirillo; Gianpaolo Tibolla; Giuseppe Danilo Norata; Alberico Luigi Catapano
Journal:  Curr Atheroscler Rep       Date:  2014-08       Impact factor: 5.113

4.  Prediction of a potentially effective dose in humans for BAY 60-5521, a potent inhibitor of cholesteryl ester transfer protein (CETP) by allometric species scaling and combined pharmacodynamic and physiologically-based pharmacokinetic modelling.

Authors:  Olaf Weber; Stefan Willmann; Hilmar Bischoff; Volkhart Li; Alexandros Vakalopoulos; Klemens Lustig; Frank-Thorsten Hafner; Roland Heinig; Carsten Schmeck; Klaus Buehner
Journal:  Br J Clin Pharmacol       Date:  2012-02       Impact factor: 4.335

Review 5.  Cholesteryl ester transfer protein and its inhibition.

Authors:  Olaf Weber; Hilmar Bischoff; Carsten Schmeck; Michael-Friedrich Böttcher
Journal:  Cell Mol Life Sci       Date:  2010-06-18       Impact factor: 9.261

Review 6.  Established and emerging approaches for the management of dyslipidaemia.

Authors:  Giuseppe Danilo Norata
Journal:  Scientifica (Cairo)       Date:  2012-09-10

7.  CoMFA, CoMSIA and eigenvalue analysis on dibenzodioxepinone and dibenzodioxocinone derivatives as cholesteryl ester transfer protein inhibitors.

Authors:  Xu-qiong Xiong; Dong-mei Zhao; Peng-fei Bu; Yang Liu; Jin-hong Ren; Jian Wang; Mao-sheng Cheng
Journal:  Molecules       Date:  2008-08-22       Impact factor: 4.411

Review 8.  High Density Lipoproteins: Metabolism, Function, and Therapeutic Potential.

Authors:  Anne Jomard; Elena Osto
Journal:  Front Cardiovasc Med       Date:  2020-03-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.